Global Nuclear Medicine Radioisotopes Market Research Report 2023
- Report Code : INT2490159
- Published On: May, 2021
- Category : Medical Devices
- Pages : 180
-
Research Predicts that Nuclear Medicine Radioisotopes Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Nuclear Medicine Radioisotopes Market Overview:
Global Nuclear Medicine Radioisotopes Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Nuclear Medicine Radioisotopes involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Nuclear Medicine Radioisotopes Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Nuclear Medicine Radioisotopes market in 2020.
Global Nuclear Medicine Radioisotopes Market Segmentation
By Type, Nuclear Medicine Radioisotopes market has been segmented into:
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Others
By Application, Nuclear Medicine Radioisotopes market has been segmented into:
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Nuclear Medicine Radioisotopes market are:
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
-
With tables and figures helping analyze worldwide Global Nuclear Medicine Radioisotopes market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1. Market Overview of Nuclear Medicine Radioisotopes1.1 Nuclear Medicine Radioisotopes Market Overview
1.1.1 Nuclear Medicine Radioisotopes Product Scope
1.1.2 Market Status and Outlook1.2 Nuclear Medicine Radioisotopes Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Nuclear Medicine Radioisotopes Historic Market Size by Regions (2015-2020)
1.4 Nuclear Medicine Radioisotopes Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Nuclear Medicine Radioisotopes Sales Market by Type (2015-2026)2.1 Global Nuclear Medicine Radioisotopes Historic Market Size by Type (2015-2020)
2.2 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Type (2021-2026)
2.3 Thallium-201 (Tl-201)
2.4 Iodine (I-123)
2.5 Fluorine-18
2.6 Rubidium-82 (Rb-82)
2.7 Others
3. Covid-19 Impact Nuclear Medicine Radioisotopes Sales Market by Application (2015-2026)3.1 Global Nuclear Medicine Radioisotopes Historic Market Size by Application (2015-2020)
3.2 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Application (2021-2026)
3.3 Tumor
3.4 Heart Disease
3.5 Lymphoma
3.6 Thyroid Gland
3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers4.1 Global Nuclear Medicine Radioisotopes Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Nuclear Medicine Radioisotopes Business5.1 Agfa-Gevaert Group
5.1.1 Agfa-Gevaert Group Company Profile
5.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Specification
5.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.2 Braco
5.2.1 Braco Company Profile
5.2.2 Braco Nuclear Medicine Radioisotopes Product Specification
5.2.3 Braco Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.3 Cardiarc
5.3.1 Cardiarc Company Profile
5.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Specification
5.3.3 Cardiarc Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.4 Cardinal Health
5.4.1 Cardinal Health Company Profile
5.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Specification
5.4.3 Cardinal Health Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.5 CMR Naviscan (Gamma Medica Inc.)
5.5.1 CMR Naviscan (Gamma Medica Inc.) Company Profile
5.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Specification
5.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.6 Curium
5.6.1 Curium Company Profile
5.6.2 Curium Nuclear Medicine Radioisotopes Product Specification
5.6.3 Curium Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Digirad
5.7.1 Digirad Company Profile
5.7.2 Digirad Nuclear Medicine Radioisotopes Product Specification
5.7.3 Digirad Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 GE Healthcare
5.8.1 GE Healthcare Company Profile
5.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Specification
5.8.3 GE Healthcare Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Nordion (Canada)
5.9.1 Nordion (Canada) Company Profile
5.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Specification
5.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)5.10 NTP Radioisotopes SOC
5.10.1 NTP Radioisotopes SOC Company Profile
5.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Specification
5.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Positron
5.11.1 Positron Company Profile
5.11.2 Positron Nuclear Medicine Radioisotopes Product Specification
5.11.3 Positron Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Segami
5.12.1 Segami Company Profile
5.12.2 Segami Nuclear Medicine Radioisotopes Product Specification
5.12.3 Segami Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Siemens Healthcare
5.13.1 Siemens Healthcare Company Profile
5.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Specification
5.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America6.1 North America Nuclear Medicine Radioisotopes Market Size (2015-2026)
6.2 North America Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
6.3 North America Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
6.4 North America Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
7. East Asia7.1 East Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)
7.2 East Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
7.3 East Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
7.4 East Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
8. Europe8.1 Europe Nuclear Medicine Radioisotopes Market Size (2015-2026)
8.2 Europe Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
8.3 Europe Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
8.4 Europe Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
9. South Asia9.1 South Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)
9.2 South Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
9.3 South Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
9.4 South Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
10. Southeast Asia10.1 Southeast Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)
10.2 Southeast Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
10.3 Southeast Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
10.4 Southeast Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
11. Middle East11.1 Middle East Nuclear Medicine Radioisotopes Market Size (2015-2026)
11.2 Middle East Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
11.3 Middle East Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
11.4 Middle East Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
12. Africa12.1 Africa Nuclear Medicine Radioisotopes Market Size (2015-2026)
12.2 Africa Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
12.3 Africa Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
12.4 Africa Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
13. Oceania13.1 Oceania Nuclear Medicine Radioisotopes Market Size (2015-2026)
13.2 Oceania Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
13.3 Oceania Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
13.4 Oceania Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
14. South America14.1 South America Nuclear Medicine Radioisotopes Market Size (2015-2026)
14.2 South America Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
14.3 South America Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
14.4 South America Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
15. Rest of the World15.1 Rest of the World Nuclear Medicine Radioisotopes Market Size (2015-2026)
15.2 Rest of the World Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)
15.3 Rest of the World Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
15.4 Rest of the World Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)
16 Nuclear Medicine Radioisotopes Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
-
The Global Nuclear Medicine Radioisotopes Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The flow of investment into the Global Nuclear Medicine Radioisotopes Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.
In recent years, the Global Nuclear Medicine Radioisotopes Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
According to the Global Nuclear Medicine Radioisotopes Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
In this highly competitive and rapidly evolving Global Nuclear Medicine Radioisotopes Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
